Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multifactorial Inheritance | 3 | 2015 | 26 | 1.270 |
Why?
|
| Body Height | 4 | 2015 | 68 | 1.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 74 | 0.800 |
Why?
|
| Genome-Wide Association Study | 5 | 2015 | 359 | 0.780 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 147 | 0.740 |
Why?
|
| Phenotype | 7 | 2023 | 1200 | 0.720 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 81 | 0.560 |
Why?
|
| Tissue Donors | 1 | 2018 | 152 | 0.540 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 313 | 0.530 |
Why?
|
| Organoids | 3 | 2024 | 43 | 0.460 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 574 | 0.460 |
Why?
|
| Genetic Vectors | 1 | 2021 | 872 | 0.450 |
Why?
|
| CRISPR-Cas Systems | 4 | 2023 | 358 | 0.440 |
Why?
|
| Dependovirus | 1 | 2021 | 709 | 0.440 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 74 | 0.410 |
Why?
|
| Crohn Disease | 1 | 2014 | 111 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 491 | 0.360 |
Why?
|
| Algorithms | 3 | 2023 | 1001 | 0.340 |
Why?
|
| Alleles | 1 | 2011 | 447 | 0.330 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 721 | 0.280 |
Why?
|
| Genome, Human | 3 | 2018 | 237 | 0.260 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 180 | 0.260 |
Why?
|
| Brain | 2 | 2024 | 1555 | 0.250 |
Why?
|
| Genetic Variation | 3 | 2018 | 383 | 0.240 |
Why?
|
| Vagus Nerve | 1 | 2024 | 21 | 0.230 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2017 | 26 | 0.230 |
Why?
|
| Immunoglobulins | 1 | 2024 | 77 | 0.230 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 91 | 0.220 |
Why?
|
| Hyaluronan Receptors | 2 | 2015 | 35 | 0.220 |
Why?
|
| Herpesvirus 1, Human | 1 | 2024 | 82 | 0.220 |
Why?
|
| Genes, Immunoglobulin | 1 | 2023 | 34 | 0.210 |
Why?
|
| Databases, Genetic | 2 | 2017 | 89 | 0.210 |
Why?
|
| Antigens, CD | 1 | 2024 | 347 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 459 | 0.200 |
Why?
|
| Thioctic Acid | 1 | 2022 | 7 | 0.190 |
Why?
|
| Hibiscus | 1 | 2022 | 2 | 0.190 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 20 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 71 | 0.180 |
Why?
|
| Microglia | 1 | 2024 | 242 | 0.180 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 668 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2022 | 248 | 0.170 |
Why?
|
| Humans | 20 | 2024 | 63281 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2017 | 2566 | 0.160 |
Why?
|
| Swine | 1 | 2021 | 374 | 0.160 |
Why?
|
| Systems Biology | 2 | 2010 | 33 | 0.160 |
Why?
|
| Mitochondria | 1 | 2023 | 371 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2022 | 151 | 0.160 |
Why?
|
| Databases, Protein | 2 | 2010 | 48 | 0.160 |
Why?
|
| Data Mining | 2 | 2010 | 38 | 0.160 |
Why?
|
| Intellectual Disability | 1 | 2022 | 172 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 218 | 0.150 |
Why?
|
| Cell Line | 1 | 2023 | 2037 | 0.150 |
Why?
|
| Gene Editing | 1 | 2023 | 318 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 321 | 0.150 |
Why?
|
| DNA, Fungal | 1 | 2018 | 58 | 0.140 |
Why?
|
| Sample Size | 1 | 2018 | 65 | 0.140 |
Why?
|
| Gene Library | 1 | 2018 | 102 | 0.140 |
Why?
|
| Geography | 1 | 2017 | 38 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 692 | 0.130 |
Why?
|
| Disease | 1 | 2017 | 27 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2017 | 186 | 0.130 |
Why?
|
| Obesity | 2 | 2014 | 1230 | 0.130 |
Why?
|
| Point Mutation | 2 | 2018 | 166 | 0.120 |
Why?
|
| Mice | 5 | 2022 | 10827 | 0.120 |
Why?
|
| F-Box Proteins | 1 | 2015 | 15 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2018 | 399 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2018 | 477 | 0.120 |
Why?
|
| Gene Frequency | 2 | 2014 | 123 | 0.120 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 32 | 0.120 |
Why?
|
| Leg Bones | 1 | 2015 | 2 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2014 | 768 | 0.120 |
Why?
|
| Homozygote | 1 | 2015 | 124 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2015 | 111 | 0.120 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2021 | 796 | 0.110 |
Why?
|
| Genes, Recessive | 1 | 2014 | 52 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 718 | 0.110 |
Why?
|
| Female | 8 | 2024 | 32777 | 0.110 |
Why?
|
| Animals | 8 | 2022 | 20631 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 197 | 0.110 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 289 | 0.110 |
Why?
|
| Proteins | 2 | 2010 | 751 | 0.110 |
Why?
|
| Albuminuria | 1 | 2014 | 31 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 37 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2021 | 789 | 0.110 |
Why?
|
| Male | 6 | 2024 | 29804 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2014 | 260 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 559 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 377 | 0.100 |
Why?
|
| Growth Plate | 1 | 2012 | 9 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 309 | 0.100 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2012 | 4 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 45 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 205 | 0.090 |
Why?
|
| Contractile Proteins | 1 | 2012 | 14 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 41 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 60 | 0.090 |
Why?
|
| Siblings | 1 | 2011 | 44 | 0.090 |
Why?
|
| Cognition | 1 | 2015 | 484 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 120 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1617 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 111 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 664 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 205 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 281 | 0.080 |
Why?
|
| Transcriptome | 2 | 2024 | 388 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 86 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 68 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 87 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2674 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 771 | 0.080 |
Why?
|
| Base Sequence | 2 | 2023 | 1329 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2012 | 626 | 0.070 |
Why?
|
| Adult | 3 | 2015 | 16774 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 879 | 0.070 |
Why?
|
| Middle Aged | 3 | 2015 | 17541 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2006 | 52 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2014 | 788 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 2024 | 50 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 66 | 0.060 |
Why?
|
| Software | 3 | 2015 | 389 | 0.050 |
Why?
|
| United States | 1 | 2017 | 7829 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 279 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 87 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 258 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 230 | 0.050 |
Why?
|
| Aged | 2 | 2024 | 14385 | 0.050 |
Why?
|
| Chromosome Disorders | 1 | 2022 | 14 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2022 | 25 | 0.050 |
Why?
|
| Thymocytes | 1 | 2022 | 21 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 42 | 0.050 |
Why?
|
| Emigration and Immigration | 1 | 2022 | 27 | 0.050 |
Why?
|
| Neoplasms | 1 | 2012 | 1359 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 114 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 147 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2023 | 661 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 174 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 6238 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 172 | 0.040 |
Why?
|
| Systems Integration | 2 | 2010 | 26 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 252 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 621 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 760 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2010 | 141 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2018 | 6 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Mutation | 2 | 2023 | 2607 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2018 | 84 | 0.040 |
Why?
|
| Biotechnology | 1 | 2018 | 43 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2018 | 117 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 174 | 0.040 |
Why?
|
| Mosaicism | 1 | 2017 | 30 | 0.030 |
Why?
|
| Zygote | 1 | 2017 | 45 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 489 | 0.030 |
Why?
|
| Internet | 2 | 2010 | 469 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 347 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 620 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2015 | 5 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 20 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 67 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 70 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 92 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 91 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 126 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 103 | 0.030 |
Why?
|
| Chaperonins | 1 | 2014 | 6 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 20 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 202 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 5443 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2014 | 69 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 145 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2015 | 122 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 275 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 441 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 692 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 937 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 509 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 75 | 0.020 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 5 | 0.020 |
Why?
|
| Filamins | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 58 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 618 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 98 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 65 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 114 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 72 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 193 | 0.020 |
Why?
|
| Zebrafish | 1 | 2014 | 347 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2012 | 107 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 207 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 199 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2012 | 149 | 0.020 |
Why?
|
| Seizures | 1 | 2012 | 143 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 517 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 671 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 356 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 370 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 116 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 153 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3759 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1649 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 1355 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 832 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1649 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2330 | 0.010 |
Why?
|